Critical Reviews in Microbiology

Papers
(The H4-Index of Critical Reviews in Microbiology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases73
TREM-2: friend or foe in infectious diseases?66
Dynamics of antibiotic resistance genes in plasmids and bacteriophages61
Salmonella in eggs and egg-laying chickens: pathways to effective control46
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids46
Paving the way forward: Escherichia coli bacteriophages in a One Health approach46
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-1945
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens43
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies39
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases38
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections36
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication33
Bile acid–gut microbiota crosstalk in irritable bowel syndrome31
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings31
Under the lens: using Raman spectroscopy as a unique system in biofilm analyses31
Exploring halophilic environments as a source of new antibiotics29
LysR-type transcriptional regulators: state of the art29
Vibrio cholerae virulence and its suppression through the quorum-sensing system27
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review25
The microbiome and precision oncology: an emerging paradigm in anticancer therapy25
The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma25
Advances in the applications of Bacteriophages and phage products against food-contaminating bacteria24
Helicobacter pylori eradication: developing antibiotic-independent antimicrobial moieties24
Emerging cellular and molecular interactions between the lung microbiota and lung diseases24
0.10205316543579